UK watchdog bans menopause treatment claims in four supplement adverts
UK watchdog bans menopause treatment claims in four supplement adverts
The Advertising Standards Authority bans four menopause supplement ads for claiming to prevent, treat or cure symptoms, citing unsubstantiated health statements.
The Advertising Standards Authority has banned four food supplement adverts that claimed their products could prevent, treat or cure menopause symptoms. The regulator said the claims were unsubstantiated and could mislead consumers at a time when many women search for relief from bothersome changes. The ruling comes after formal complaints and a review of how menopause is presented in wellness marketing.
The brands named were 222 Balance Me, Lunera, Minerva and Nova Menopause Vitality. Each advert asserted that their supplement could address menopause symptoms or disease-like conditions, which the ASA said went beyond what is permitted for dietary supplements.
The ASA stressed that claims about preventing or curing a health condition require solid evidence from reliable studies. Ads that imply a product can treat menopause are treated as medical claims and must meet stricter rules. The decision signals tighter scrutiny of wellness marketing aimed at women.
Advertisers are now expected to remove or amend the disputed claims, and further breaches could attract sanctions. For consumers, the case reinforces the importance of checking the evidence behind health statements in supplements.
